The significant association between family history of asthma and omalizumab treatment (p=0.043) may reflect the allergic phenotype for which omalizumab is typically prescribed, as it targets immunoglobulin (Ig)E-mediated allergic responses [9]. Here, IGHE is linked to asthma.